Cerebral spinal fluid complement and antinuclear auto antibodies in lupic meningoencephalitis;Complement et anticorps anti-nucleaires cephalo-rachidiens dans une meningo-encephalite lupique

Revue Neurologique

Volumn 154, Issue 6-7, 1998, Pages 549-550

  Hazouard, E ^a   Legras, A ^a   Diot, E ^a   Ferrandiere M ^a   Corcia, P ^a   Ginies G ^a  

^a CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; ANTINUCLEAR ANTIBODY; COMPLEMENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASTHENIA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMA; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MENINGOENCEPHALITIS; NYSTAGMUS; SYSTEMIC LUPUS ERYTHEMATOSUS; CEREBROSPINAL FLUID; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, ANTINUCLEAR; COMPLEMENT SYSTEM PROTEINS; CYCLOPHOSPHAMIDE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENINGOENCEPHALITIS; MIDDLE AGED;

EID: 0031858544     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. HANSON V.G., HOROWITZ M., ROSENBLUTH D., SPIERA H., PUSZKIN S. (1992). Systemic lupus erythematous patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med, 176: 565-73.
2. KAHN M.F., MEYER O., PELTIER A.P., PIETTE J.C. (1991). Lupus érythémateux disséminé. In : Les maladies systémiques, 289-90. Flammarion, Paris.
3. MAC LEAN B.N., MILLER D., THOMPSON E.J. (1995). Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus érythématosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry, 58: 548-54.
4. MILLS J.A. (1994). Systemic lupus erythematosus. N Engl J Med, 330: 1871-9.
5. PETZ L.D., SHARP G.G., COOPER N.R., IRVIN W.S. (1971). Serum and cerebral spinal fluid complement and serum auto antibodies in systemic lupus erythematosus. Medicine, 50: 259-75.
6. SANDERS M.E., ALEXANDER E.L., KOSKI C.L., FRANK M.M., JOINER K.A. (1987). Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjögren's syndrome and systemic lupus erythematosus. J Immunol, 138: 2095-9.